U.S. health advisers recommended on Thursday that the American population should widely be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots.
As it stands, the panel’s advice may or may not be adopted by the CDC, especially since it is quite an unusual move. “The strange clotting problem has caused nine confirmed deaths after J&J vaccinations — while the Pfizer and Moderna vaccines don’t come with that risk and also appear to be more effective,” advisers to the Centers for Disease Control and Prevention said.
The J&J vaccine, being a single-shot one, had, until now been preferred for several sections of the population, specifically for its convenience, unlike the two-dose jabs from Pfizer and Moderna. But the CDC’s advisers said Thursday that it was time to recognize a lot has changed since vaccines began rolling out a year ago. More than 200 million Americans are considered fully vaccinated, including about 16 million who got the J&J shot, and it is now okay to pick whichever the safest vaccine is.
Several other countries already have recommended age restrictions for both the AstraZeneca and J&J vaccines, or that preference be given to the Pfizer and Moderna vaccines.